Published in Biochem Pharmacol on October 15, 1987
Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest (1997) 1.66
2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity. Br J Pharmacol (1990) 1.11
Analgesic and anti-inflammatory studies of cyclopeptide alkaloid fraction of leaves of Ziziyphus nummularia. Saudi J Biol Sci (2013) 0.87
Induction of inflammatory cell infiltration and necrosis in normal mouse skin by the combined treatment of tumor necrosis factor and lithium chloride. Am J Pathol (1991) 0.77
Reduced endotoxin-induced production of tumor necrosis factor activity by equine peritoneal macrophages exposed to the dual inhibitor of arachidonic acid metabolism, SK & F 86002. Can J Vet Res (1992) 0.75
Effects of pyridinyl imidazole compounds on murine TNF-alpha production. Agents Actions (1993) 0.75
Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol (1966) 14.57
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47
Measurement of the translational mobility of concanavalin A in glycerol-saline solutions and on the cell surface by fluorescence recovery after photobleaching. Biochim Biophys Acta (1976) 6.04
The pathogenesis of cancer metastasis. Nature (1980) 5.74
Chromosome structure in phage T4, II. Terminal redundancy and heterozygosis. Proc Natl Acad Sci U S A (1965) 4.91
Measurement of the lateral mobility of cell surface components in single, living cells by fluorescence recovery after photobleaching. J Supramol Struct (1976) 4.40
Membrane fusion. Biochim Biophys Acta (1973) 3.75
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature (1999) 3.20
Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim Biophys Acta (1975) 2.62
In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res (1980) 2.40
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem (1998) 2.32
Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology (1998) 2.30
Local anesthetics affect transmembrane cytoskeletal control of mobility and distribution of cell surface receptors. Proc Natl Acad Sci U S A (1975) 2.26
Becoming a doctor in China. Lancet (1991) 2.21
Studies on membrane fusion. III. The role of calcium-induced phase changes. Biochim Biophys Acta (1977) 2.15
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology. Ann Surg Oncol (2006) 2.13
Molecular basis of a mutational hot spot in the lysozyme gene of bacteriophage T4. Nature (1972) 2.08
A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J Natl Cancer Inst (1984) 2.08
Why is osteoarthritis of the hip more common on the right? Lancet (1993) 2.05
p40MO15, a cdc2-related protein kinase involved in negative regulation of meiotic maturation of Xenopus oocytes. EMBO J (1990) 1.96
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Effects of local anesthetics on membrane properties. I. Changes in the fluidity of phospholipid bilayers. Biochim Biophys Acta (1975) 1.89
Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proc Natl Acad Sci U S A (1981) 1.87
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
Clomiphene as a test of pituitary function. Lancet (1971) 1.81
Mechanisms of virus-induced cell fusion. Int Rev Cytol (1972) 1.79
SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol (2000) 1.75
Membrane fusion and molecular segregation in phospholipid vesicles. Biochim Biophys Acta (1974) 1.73
The central effects of a novel dopamine agonist. Eur J Pharmacol (1978) 1.73
Lipid vesicles as carriers for introducing biologically active materials into cells. Methods Cell Biol (1976) 1.70
Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest (1997) 1.70
Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J Pharmacol Exp Ther (1982) 1.69
Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature (1999) 1.68
Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U S A (1980) 1.65
Screening colonoscopy in asymptomatic average-risk African Americans. Gastrointest Endosc (2000) 1.65
Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br J Pharmacol (2000) 1.64
Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. Biochim Biophys Acta (1973) 1.63
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother (1997) 1.62
Clinical guidelines. BMJ (1997) 1.62
Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J Exp Med (1989) 1.60
Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo. J Immunol (1981) 1.58
Hospital family planning: a yough advisory clinic. Br Med J (1971) 1.58
Mapping the range and scope of emergency nurse practitioner services in the Northern and Yorkshire Region: a telephone survey. Emerg Med J (2003) 1.52
Studies on membrane fusion. II. Induction of fusion in pure phospholipid membranes by calcium ions and other divalent metals. Biochim Biophys Acta (1976) 1.51
The cancer cell: dynamic aspects and modifications in cell-surface organization (first of two parts). N Engl J Med (1976) 1.51
Role of natural killer cells in the destruction of circulating tumor emboli. J Natl Cancer Inst (1980) 1.49
Lipid vesicles as carriers for introducing materials into cultured cells: influence of vesicle lipid composition on mechanism(s) of vesicle incorporation into cells. Proc Natl Acad Sci U S A (1976) 1.48
Depo Provera. Position paper on clinical use, effectiveness and side effects. Br J Fam Plann (1999) 1.48
Induction of T-cell immunity against Ras oncoproteins by soluble protein or Ras-expressing Escherichia coli. J Natl Cancer Inst (1995) 1.47
An agenda for change in referral--consensus from general practice. Br J Gen Pract (1994) 1.47
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol (2001) 1.47
Effects of local anesthetics on membrane properties. II. Enhancement of the susceptibility of mammalian cells to agglutination by plant lectins. Biochim Biophys Acta (1975) 1.46
Targeted anti-cancer therapy using rituximab, a chimaeric anti-CD20 antibody (IDEC-C2B8) in the treatment of non-Hodgkin's B-cell lymphoma. Biochem Soc Trans (1997) 1.45
Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J Neurosci Res (1991) 1.45
Intrauterine contraception with the copper 7: evaluation after two years. Br Med J (1974) 1.44
Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. Biochemistry (1997) 1.44
Parent comprehension of polio vaccine information pamphlets. Pediatrics (1996) 1.44
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators. Cancer Res (1982) 1.40
Delayed recognition of podophyllum toxicity in a patient receiving epidural morphine. Anesth Analg (1990) 1.40
Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs. Cancer Biother Radiopharm (1997) 1.40
Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci U S A (1985) 1.38
SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J Pharmacol Exp Ther (2000) 1.37
Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol (2001) 1.34
Continuous intrauterine copper contraception for 3 years: comparison of replacement at 2 years with continuation of use. Br Med J (1977) 1.33
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res (1982) 1.32
Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers. Int J Radiat Oncol Biol Phys (2000) 1.32
Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases. Proc Natl Acad Sci U S A (1982) 1.31
Expression of metastatic potential of tumor cells in young nude mice is correlated with low levels of natural killer cell-mediated cytotoxicity. Int J Cancer (1980) 1.31
Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone. J Pharmacol Exp Ther (2001) 1.31
Herpesvirus hominis infection of the female genital tract. Obstet Gynecol (1972) 1.31
Analysis of IL10 haplotypic associations with severe malaria. Genes Immun (2005) 1.29
Characterization of the dog Agouti gene and a nonagoutimutation in German Shepherd Dogs. Mamm Genome (2004) 1.28
Virus-induced polykaryocytosis and the mechanism of cell fusion. Adv Virus Res (1970) 1.28
Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem (1994) 1.28
SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet (2009) 1.28
Developmental changes in heart period and high-frequency heart period variability from 4 months to 4 years of age. Dev Psychobiol (2000) 1.27
Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM (2008) 1.27
Hospital family planning: termination of pregnancy and contraceptive use. Br Med J (1973) 1.25
Inhibition of T suppressor cell expression by histamine type 2 (H2) receptor antagonists. J Immunol (1984) 1.25
On the genesis and regulation of cellular heterogeneity in malignant tumors. Invasion Metastasis (1982) 1.25
Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4. J Immunol (2000) 1.23
Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages. Cancer Res (1980) 1.23
SK&F 36914--an agent for oral chrysotherapy. J Pharmacol Exp Ther (1972) 1.23
Adjuvant-induced arthritis in rats. II. Drug effects on physiologic, biochemical and immunologic parameters. J Pharmacol Exp Ther (1971) 1.22
Intrauterine contraception using the copper-seven device. Lancet (1972) 1.22
Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (1985) (2011) 1.21
Use of melatonin in recovery from jet-lag following an eastward flight across 10 time-zones. Ergonomics (2000) 1.17
Membrane fusion reaction: a theory. J Theor Biol (1971) 1.17
Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev (2003) 1.16
Conveying the benefits and risks of treatment. Br J Gen Pract (1995) 1.16
Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res (1998) 1.15
Role of natural killer cells in control of cancer metastasis. Cancer Metastasis Rev (1982) 1.15
Effects of local anesthetics on cell morphology and membrane-associated cytoskeletal organization in BALB/3T3 cells. J Cell Biol (1976) 1.15
Induction of 32- and 34-kDa stress proteins by sodium arsenite, heavy metals, and thiol-reactive agents. J Biol Chem (1986) 1.14
EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes. J Mol Cell Cardiol (2001) 1.14